B
BridgeBio Pharma, Inc. (BBIO)
69.70
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
69.70
0.00 (0.00%)
This stock has a consensus price target of $82.08 based on the ratings of 27 analysts. The high is $125.00 and the low is $37.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 37 | $ 82.08 | $ 125 |
| O’zgarish | -46.92% | 17.76% | 79.34% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-18 | 52.08% | Mizuho | $91 → $106 | Maintains | Outperform |
| 2026-03-10 | 34.86% | JP Morgan | $89 → $94 | Maintains | Overweight |
| 2026-03-10 | — | William Blair | — | Initiates Coverage On | Outperform |
| 2026-02-25 | 36.3% | Truist Securities | $86 → $95 | Maintains | Buy |
| 2026-02-25 | 16.21% | Oppenheimer | $83 → $81 | Maintains | Outperform |